Table 2.
Result of investigating screening for recurrent pregnancy losses (checked on March 24, 2008)
| Basal hormonal profile | Value | Antiphospholipid syndrome screening | Value |
|---|---|---|---|
| LH (IU/L) | 3.7 | IgM anticardiolipin antibody titers (U/mL) | <5000 |
| FSH (IU/L) | 10.2 | IgG anticardiolipin antibody titers (U/mL) | 1000 |
| Prolactin (ng/mL) | 6.3 | LAC (dilute Russell viper venom time) | 0.800 |
| Blood coagulation testing | Anti‐PE IgG (kininogen+) | 0.206 | |
| PT (second) | 11.0 | Anti‐PE IgM | 0.370 |
| APTT (second) | 25.6 | Anti‐PS IgG | <0.500 |
| Protein S | 71.0 | Anti‐PS IgM | 0.600 |
| Protein C (%) | 104.0 | β2GP1 antibody | <0.200 |
| Coagulation factor XII (%) | 138.0 | Autoimmune screening | |
| Full blood count | Anti‐DNA | <80 000 | |
| White blood cells (/μL) | 4700.0 | Mitochondrial antibodies | <20 000 |
| Red blood cells (million/μL) | 372.0 | Thyroid antibodies (IU/mL) | 1200 |
| Hemoglobin (g/dl) | 11.7 | Viral screening | |
| Platelets (/μL) | 267,000.0 | Hepatitis B antigen | Negative |
| Random blood sugar count (g/dl) | 98.0 | Hepatitis C antibody | Negative |
| Thyroid gland profile | <20.0 | Human immunosuppressive virus | Negative |
| TSH (μIU/mL) | 1.7 | Karyotype analysis of both parents | |
| Free T3 (pg/mL) | 3.6 | Patient | 46, XX |
| Free T4 (ng/mL) | 1.5 | Partner | 46, XY |
APTT, activated partial thromboplastin time; FSH, follicle‐stimulating hormone; GP, glycoprotein; Ig, immunoglobulin; LAC, lupus anticoagulant; LH, luteinizing hormone; PE, phosphatidylethanolamine; PS, phosphatidylserine; PT, prothrombin time; TSH, thyroid stimulating hormone.